Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LCK | P06239 | 1/20 | 0.58 |
| ▸ | HDAC1 | Q13547 | 4/20 | 0.58 |
| ▸ | HDAC6 | Q9UBN7 | 4/20 | 0.58 |
| ▸ | PARP1 | P09874 | 1/20 | 0.55 |
| ▸ | PARP3 | Q9Y6F1 | 1/20 | 0.55 |
| ▸ | MDM4 | O15151 | 1/20 | 0.55 |
| ▸ | MDM2 | Q00987 | 1/20 | 0.55 |
| ▸ | ERCC1 | P07992 | 1/20 | 0.54 |
| ▸ | ERCC4 | Q92889 | 1/20 | 0.54 |
| ▸ | APP | P05067 | 1/20 | 0.53 |
| ▸ | ATM | Q13315 | 1/20 | 0.53 |
| ▸ | POLB | P06746 | 2/20 | 0.53 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.52 |
| ▸ | THRB | P10828 | 1/20 | 0.52 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.52 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.52 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.52 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6139811 | 0.92 | LCK (0.67) | LCKHDAC1HDAC6APPALDH1A1 | |
| SCHEMBL4145473 | 0.88 | HDAC1 (0.63) | HDAC1HDAC6PARP1PARP3MDM4 | |
| SCHEMBL4145476 | 0.88 | HDAC1 (0.63) | HDAC1HDAC6PARP1PARP3MDM4 | |
| SCHEMBL5966500 | 0.88 | HDAC1 (0.63) | HDAC1HDAC6PARP1PARP3MDM4 | |
| SCHEMBL4149824 | 0.88 | MDM4 (0.67) | HDAC1HDAC6PARP1PARP3MDM4 | |
| SCHEMBL4153061 | 0.88 | MDM4 (0.67) | HDAC1HDAC6PARP1PARP3MDM4 | |
| SCHEMBL4153058 | 0.88 | MDM4 (0.67) | HDAC1HDAC6PARP1PARP3MDM4 | |
| SCHEMBL4149820 | 0.88 | MDM4 (0.67) | HDAC1HDAC6PARP1PARP3MDM4 | |
| SCHEMBL28349735 | 0.85 | GAA (0.60) | LCKAPPPOLB | |
| SCHEMBL28349736 | 0.85 | GAA (0.60) | LCKAPPPOLB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20030199566-A1 | Phenolic acid derivatives and composition for preventing or treating blood lipid level-related diseases comprising the same | BIONUTRIGEN CO., LTD. (KR) | 2003-10-23 | — | — | US | claimed |
| US-7223793-B2 | Phenolic acid derivatives and composition for preventing or treating blood lipid level-related diseases comprising the same | BIONUTRIGEN CO., LTD. (KR) | 2007-05-29 | — | — | US | disclosed |
| US-20030199566-A1 | Phenolic acid derivatives and composition for preventing or treating blood lipid level-related diseases comprising the same | BIONUTRIGEN CO., LTD. (KR) | 2003-10-23 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030199566-A1 | Phenolic acid derivatives and composition for preventing or treating blood lipid level-related diseases comprising the same | NCEH1, HMGCR, DBH | LCK 3818/4885HDAC1 784/4885HDAC6 2679/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.